Why the study?
To analyze the scientific literature on comorbidity of CAD and assess its impact on the results of CABG.
How do comorbidities such as COPD, metabolic syndrome, and diabetes mellitus impact the outcomes and survival of patients with coronary artery disease undergoing coronary artery bypass grafting?
How do comorbidities such as COPD, metabolic syndrome, and diabetes mellitus impact the outcomes and survival of patients with coronary artery disease undergoing coronary artery bypass grafting?
Answers are grounded in this paper and cite their sources.
Comorbidities such as COPD, metabolic syndrome, and diabetes significantly worsen short- and long-term outcomes after CABG, highlighting the need for personalized risk management.
The review presents an analysis of the scientific literature on comorbidity of coronary artery disease (CAD) and assessment of its impact on the results of coronary artery bypass grafting (CABG). Arterial hypertension (AH), chronic obstructive pulmonary disease (COPD), metabolic syndrome (MS), and diabetes mellitus (DM) have been shown to be the most common comorbidities in CAD patients. Clinical manifestations of cardiovascular comorbidities also include atrial fibrillation, acute cerebral ischemia, atherosclerosis of carotid and lower limb arteries, and chronic heart failure. Concomitant COPD doubles the risk of postoperative complications after CABG and reduces the 10-year survival rate in patients to 30%. In CAD patients with MS, the risk of postoperative mortality increases by 1.4 times, and the 5-year survival rate decreases by 3 times. Diabetes significantly worsens the long-term survival of patients after CABG and is an independent predictor of acute cardiovascular events after revascularization in the long term. The presence of various comorbidities in CAD patients requires a personalized approach to managing the risks of adverse outcomes after CABG and introduction of modern artificial intelligence (AI) technologies into clinical practice, which significantly increase the accuracy of prognosis.
No takes yet. Share an insight, caveat, or question.
Rublev et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: